Immunology
From the Journals
New Criteria Identify Sepsis in Children With Infection
Latest News
New tests may finally diagnose long COVID
“I was gobsmacked by the results. We’re seeing a massive dysregulation in those four biomarkers. It’s a combination that we showed was predictive...
Latest News
Psychosocial environmental factors may drive persistent childhood asthma
Groups of children exposed to bad trajectories of psychosocial factors were significantly more likely to have transient high and persistent high...
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Latest News
Parent concerns a factor when treating eczema in children with darker skin types
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...
Conference Coverage
Sepsis mortality greater in Black than White children despite similar interventions
The findings reveal how structural racism and inequalities built into the U.S. health care system put Black children and other communities at...
Conference Coverage
Survey: 42% of PCPs not familiar with biologics for asthma
“The results of the survey point to the need to improve the communication between primary care physicians and asthma care specialists, including...
Conference Coverage
Alpha-gal syndrome: Red meat is ‘just the beginning,’ expert says
“We are seeing increasing diagnoses of AGS in places that are not, perhaps, where we first thought this allergy existed.”
Latest News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
Conference Coverage
Dupilumab promising for children aged 1-11 with EoE
Dupilumab was recently approved for adult EOE. It’s been shown to have a good safety profile in adults.